AVITA Medical Cash Flow Statement (2018-2025) | RCEL

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-5.64M-6.00M-10.71M-16.66M-9.46M-5.59M21.41M-9.22M-10.38M-8.71M-7.07M-18.66M-15.39M-16.20M-11.58M-13.86M-9.92M-13.19M-1.41M
Depreciation and Depletion (Quarter)
0.14M0.14M0.28M0.43M0.13M0.13M0.12M0.13M0.14M0.16M0.18M0.19M0.19M0.29M0.34M0.39M0.40M0.42M0.40M
Share-based Compensation (Quarter)
0.35M1.33M2.74M4.58M2.93M1.44M2.50M2.64M1.14M2.43M2.17M2.59M4.03M4.08M2.80M2.69M2.67M2.78M1.37M
Gains from Investment Securities (Quarter)
0.87M-2.06M0.79M0.67M-0.38M-1.15M-0.04M-0.62M
Asset Writedowns and Impairment (Quarter)
-0.01M0.02M
Cash from Operations (Quarter)
-5.67M-8.54M-12.54M-13.13M-9.37M6.84M-9.07M-9.10M-8.97M-10.86M-20.86M-12.78M-7.21M-8.08M-10.31M-10.23M-5.22M-5.44M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.16M0.17M0.34M0.52M0.16M0.13M-0.24M0.14M0.15M0.16M0.19M0.20M0.20M0.31M0.41M0.52M0.55M0.57M0.70M
Change in Working Capital
Change in Receivables (Quarter)
0.43M-0.29M-1.54M-1.20M-0.36M1.11M-1.16M-1.28M-0.03M-1.70M0.50M-1.65M-1.51M-1.49M-0.25M1.63M2.34M-0.08M
Change in Inventory (Quarter)
0.62M-0.25M-0.39M0.29M-0.23M0.46M0.75M0.25M1.40M1.29M1.66M-0.31M-0.31M1.12M1.44M-0.63M-0.14M-0.20M
Change in Accured Expenses (Quarter)
-1.70M-0.01M0.06M0.07M-2.45M2.81M-0.24M0.02M0.57M-0.08M-0.11M-0.24M0.28M-1.26M-2.10M3.01M0.81M1.04M
Other Working Capital Changes (Quarter)
-0.24M0.54M0.52M0.32M-0.07M0.53M-0.01M0.31M1.76M-1.61M1.86M-0.08M-0.47M-0.94M-0.35M-0.03M0.12M-0.51M
Investing Activities
Capital Expenditures (Quarter)
-0.06M0.53M0.02M0.76M0.30M-1.06M9.000.58M0.50M0.30M1.15M-0.81M0.07M-0.29M0.22M0.07M0.23M0.11M
Change in Acquisitions & Divestments (Quarter)
3.00M11.89M24.27M21.12M2.40M-62.92M19.20M18.00M24.00M10.00M11.00M11.00M3.50M2.00M
Cash from Investing Activities (Quarter)
-0.34M-0.36M-0.53M-50.18M-22.60M56.61M18.79M18.36M21.76M-57.30M15.07M12.43M7.39M2.47M10.77M7.02M-5.34M0.01M
Financing Activities
Other financing activities (Quarter)
0.03M-0.25M0.07M0.00M-0.03M0.90M0.17M0.17M0.60M0.01M0.63M0.06M1.01M0.43M0.36M0.01M0.03M0.00M
Cash from Financing Activities (Quarter)
-0.01M64.03M-12.86M64.06M0.00M-64.02M-64.06M0.17M0.17M0.60M39.43M0.63M0.85M1.01M1.02M0.36M0.56M13.77M0.25M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
69.11M69.11M
Additional items
Exchange Rate Effect (Quarter)
0.03M-0.01M-0.01M-0.06M-0.01M0.04M0.00M0.00M-0.02M-0.00M
Change in Cash (Quarter)
-5.99M55.11M50.98M-50.26M-31.98M-5.65M9.89M9.44M13.37M-28.74M-5.17M0.50M1.19M-4.59M0.82M-2.65M3.21M-5.18M
Free Cash Flow (Quarter)
-5.62M-9.07M-12.56M-13.89M-9.68M7.91M-9.07M-9.68M-9.48M-11.16M-22.01M-11.97M-7.28M-7.79M-10.53M-10.30M-5.45M-5.54M
Net Cash Flow (Quarter)
-6.02M55.12M-25.92M0.75M-31.97M-64.02M-0.61M9.88M9.43M13.39M-28.73M-5.17M0.50M1.19M-4.59M0.82M-2.65M3.21M-5.18M